3 research outputs found
Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis
Acknowledgements: OPG-Fc was a kind gift from Amgen Ltd. Funding: This work was supported by Arthritis Research UK, grant number 18769Peer reviewedPublisher PD